Sort   by:  
 Page size 
UnknownSpecific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.
Not available
S-EPMC7680360 | biostudies-literature
UnknownClinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.
Not available
S-EPMC5765991 | biostudies-literature
UnknownA Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale.
Not available
S-EPMC9881423 | biostudies-literature
UnknownFOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
Not available
S-EPMC6428631 | biostudies-literature
UnknownClinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.
Not available
S-EPMC5698142 | biostudies-literature
UnknownKRAS inhibition in metastatic colorectal cancer: An update.
Not available
S-EPMC9908842 | biostudies-literature
UnknownOvercoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway Targeting.
Not available
S-EPMC7453631 | biostudies-literature
UnknownA Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
Not available
S-EPMC8634406 | biostudies-literature
UnknownMolecular Pathways and Mechanisms of BRAF in Cancer Therapy.
Not available
S-EPMC9616966 | biostudies-literature
UnknownRare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition.
Not available
S-EPMC6546234 | biostudies-literature
Sort   by:  
 Page size